Bronch-EX

  • Research type

    Research Study

  • Full title

    Early Detection of Pulmonary Exacerbations in non-CF Bronchiectasis

  • IRAS ID

    323297

  • Contact name

    Andres Floto

  • Contact email

    arf27@cam.ac.uk

  • Sponsor organisation

    Royal Papworth NHS Foundation Trust

  • Duration of Study in the UK

    2 years, 7 months, 30 days

  • Research summary

    Bronchiectasis is a condition where the lungs are permanently widened and damaged. Excess mucus and persistent bacteria lead to frequent infections and problems with breathing such as cough and sputum production.

    In addition, for many patients the daily symptoms of the disease are accompanied by unpredictable worsening of symptoms which are more than normal day to day variation. These episodes are known as exacerbations and can have a big impact on patients' daily lives and their life expectancy.

    Exacerbations are of critical importance in bronchiectasis and the main goal of treatment is to reduce exacerbation frequency.

    The aim of this study is to determine if home monitoring data and artificial intelligence (AI) can be used to detect pulmonary exacerbations before symptoms become clinically apparent.

    Secondary aims of this study include
    a) to assess the acceptability of home monitoring in patients with bronchiectasis
    b) to better understand the development of pulmonary exacerbations through the
    collection of medical history and daily sputum collection.
    c) to assess adherence to inhaled therapies in those participants who use a Pari
    eFlow rapid nebuliser with Pari Connect system for inhaled medications.

    If this research shows it is possible to detect exacerbations before they become clinically apparent and / or improves understanding of the pathogenesis (process where infection leads to disease) of exacerbations, future research studies will evaluate interventions designed to curtail the development of exacerbations and the subsequent impact on health-related quality of life and bronchiectasis disease progression.

  • REC name

    West of Scotland REC 5

  • REC reference

    23/WS/0128

  • Date of REC Opinion

    27 Sep 2023

  • REC opinion

    Further Information Favourable Opinion